132 related articles for article (PubMed ID: 12796035)
1. Minidose warfarin is associated with a high incidence of International Normalized Ratio elevation during chemotherapy with FOLFOX regimen.
Magagnoli M; Masci G; Carnaghi C; Zucali PA; Castagna L; Morenghi E; Santoro A
Ann Oncol; 2003 Jun; 14(6):959-60. PubMed ID: 12796035
[No Abstract] [Full Text] [Related]
2. [Two cases of interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and Leucovorin (FOLFOX)].
Ohori H; Takahashi M; Ogasawara N; Suzuki M; Miyate Y; Kato S
Gan To Kagaku Ryoho; 2009 Feb; 36(2):295-8. PubMed ID: 19223749
[TBL] [Abstract][Full Text] [Related]
3. Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer.
Shitara K; Munakata M; Muto O; Kasai M; Okada R; Mitobe S; Sakata Y
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1079-84. PubMed ID: 17637544
[TBL] [Abstract][Full Text] [Related]
4. Effect of leucovorin on 5-fluorouracil induced inhibition of thymidylate synthase in patients with colon cancer.
Peters GJ; van Groeningen CJ; van der Wilt CL; Smid K; Meijer S; Pinedo HM
Adv Exp Med Biol; 1991; 309A():131-4. PubMed ID: 1789191
[No Abstract] [Full Text] [Related]
5. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
[TBL] [Abstract][Full Text] [Related]
6. [Epiphora in a patient receiving FOLFOX therapy].
Yatsuda C; Niimi M; Ono Y; Uto N; Iwagami E; Tanaka E; Yamato M
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1989-91. PubMed ID: 19011359
[TBL] [Abstract][Full Text] [Related]
7. [A case of locally advanced rectal cancer responding to FOLFOX].
Kume S; Kubota T; Takahashi M; Hashimoto D; Hirata T; Torigoe Y; Ikeda O
Gan To Kagaku Ryoho; 2009 Apr; 36(4):659-61. PubMed ID: 19381043
[TBL] [Abstract][Full Text] [Related]
8. Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?
Masci G; Magagnoli M; Zucali PA; Castagna L; Carnaghi C; Sarina B; Pedicini V; Fallini M; Santoro A
J Clin Oncol; 2003 Feb; 21(4):736-9. PubMed ID: 12586814
[TBL] [Abstract][Full Text] [Related]
9. Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients.
Goldstein D; Mitchell P; Michael M; Beale P; Friedlander M; Zalcberg J; White S; Clarke S
Br J Cancer; 2005 Mar; 92(5):832-7. PubMed ID: 15756253
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.
Chang YY; Lin JK; Jiang JK
Colorectal Dis; 2012 Dec; 14(12):e821. PubMed ID: 22330089
[No Abstract] [Full Text] [Related]
11. [Efficacy and safety of bevacizumab (BEV) plus chemotherapeutic agents in the treatment of metastatic colorectal cancer, mCRC].
Guo X; Liu TS; Yu YY; Zhou YH; Chen Y; Zhuang RY; Cui YH
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):604-7. PubMed ID: 24314219
[TBL] [Abstract][Full Text] [Related]
12. NCCN guideline updates: colon and rectal cancers, version 1.2004.
National Comprehensive Cancer Network
J Natl Compr Canc Netw; 2004 Jul; 2(4):284-5. PubMed ID: 19795595
[No Abstract] [Full Text] [Related]
13. [Clinical significance of a transient increase in carcinoembryonic antigen and carbohydrate antigen 19-9 in patients with metastatic colorectal cancer receiving chemotherapy].
Li YH; An X; Xiang XJ; Wang ZQ; Wang FH; Feng F; Jiang WQ; He YJ; Xu RH
Ai Zheng; 2009 Sep; 28(9):939-44. PubMed ID: 19728911
[TBL] [Abstract][Full Text] [Related]
14. Liver resection after FOLFOX with bevacizumab.
Mickle M; Mulcahy MF
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):12-4. PubMed ID: 17491587
[No Abstract] [Full Text] [Related]
15. [Role of pharmacokinetic monitoring of serum fluorouracil concentration in patients with local advanced and metastatic colorectal cancer and further improving efficacy of fluorouracil-based chemotherapy].
Cai X; Xue P; Song WF; Hu J; Gu HL; Yang HY; Wang LW
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):39-43. PubMed ID: 22490854
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of CPT-11 combined 5-FU/CF (FOLFIRI) regimen on advanced colorectal cancer].
Luo HY; Li YH; Zhang L; Jiang WQ; Shi YX; Wang F; He YJ; Xu RH
Ai Zheng; 2007 Aug; 26(8):905-8. PubMed ID: 17697557
[TBL] [Abstract][Full Text] [Related]
17. [A case of rectal cancer with liver metastases successfully treated with modified FOLFOX6 therapy].
Shoji T; Takahashi Y; Matsuda I; Suzuki K; Misumi K; Taniguchi M; Yamazaki M; Yonekawa H
Gan To Kagaku Ryoho; 2009 Sep; 36(9):1579-81. PubMed ID: 19755838
[TBL] [Abstract][Full Text] [Related]
18. Modification of leucovorin dose within a simplified FOLFOX regimen improves tolerability without compromising efficacy.
Clarke S; Goldstein D; Mitchell P; Michael M; Beale P; Friedlander M; Zalcberg J; White S
Clin Colorectal Cancer; 2007 Jul; 6(8):578-82. PubMed ID: 17681104
[TBL] [Abstract][Full Text] [Related]
19. [A case or resection of synchronous multiple liver metastases from rectal cancer after FOLFOX4 therapy].
Deguchi Y; Endo S; Tanaka J; Kasugai H; Ikehara K; Hidaka E; Hashimoto M; Ishida F; Kudo SE
Gan To Kagaku Ryoho; 2010 Jun; 37(6):1159-62. PubMed ID: 20567128
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab-associated reversible hypotension.
Iqbal K; Chu Q; Mei Q; Chen Y
Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):800-1. PubMed ID: 17825542
[No Abstract] [Full Text] [Related]
[Next] [New Search]
